Gastrointestinal stromal tumors: Pathology and prognosis at different sites

Seminars in Diagnostic Pathology

Volumn 23, Issue 2, 2006, Pages 70-83

  Miettinen, Markku ^a   Lasota, Jerzy ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Extragastrointestinal GIST; Histopathology Immunohistochemical markers; Prognosis; Small intestine; Stomach

Indexed keywords

STEM CELL FACTOR RECEPTOR;

APPENDIX TUMOR; ARTICLE; COLON TUMOR; DISEASE PREDISPOSITION; DUODENUM TUMOR; ESOPHAGUS TUMOR; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL TRACT; HISTOLOGY; HISTOPATHOLOGY; HUMAN; ILEUM TUMOR; INTERSTITIAL CELL OF CAJAL; INTESTINE TUMOR; JEJUNUM TUMOR; MESENCHYMOMA; METASTASIS; MITOSIS RATE; MORBIDITY; NEUROFIBROMATOSIS; NONHUMAN; ONCOGENE C KIT; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; RECTUM TUMOR; SARCOMA; STATISTICAL ANALYSIS; STEM CELL; STOMACH TUMOR; TUMOR DIAGNOSIS; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

ADOLESCENT; ANIMALS; CHILD; GASTROINTESTINAL STROMAL TUMORS; GASTROINTESTINAL TRACT; HUMANS; IMMUNOHISTOCHEMISTRY; MUSCLE CELLS; NEUROFIBROMATOSIS 1; NEURONS; PROGNOSIS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; TUMOR MARKERS, BIOLOGICAL;

EID: 33750618188     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semdp.2006.09.001     Document Type: Article

References (91)

1. Hirota S., Isozaki K., Moriyama Y., et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279 (1998) 577-580
2. Kindblom L.G., Remotti H.E., Aldenborg F., et al., Gastrointestinal pacemaker cell tumor (GIPACT). Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 153 (1998) 1259-1269
3. Miettinen M., and Lasota J. Gastrointestinal stromal tumors (GISTs): -Definition, occurrence, pathology, differential diagnosis and molecular genetic features. Pol J Pathol 54 (2003) 3-24
4. Lee J.R., Joshi V., Griffin Jr. J.W., et al. Gastrointestinal autonomic nerve tumor: immunohistochemical and molecular identity with gastrointestinal stromal tumor. Am J Surg Pathol 25 (2001) 979-987
5. Antonescu C.R., Viale A., Sarran L., et al. Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site. Clin Cancer Res 10 (2004) 3282-3290
6. Subramanian S., West R.B., Corless C.L., et al. Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles. Oncogene 23 (2004) 7780-7790
7. Demetri G., van Mehren M., Blanke C.D., et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347 (2002) 472-480
8. Miettinen M., Sarlomo-Rikala M., Sobin L.H., et al. Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol 24 (2000) 211-222
9. Kim K.M., Kang D.W., Moon W.S., et al. Gastrointestinal stromal tumors in Koreans: its incidence and the clinical, pathologic and immunohistochemical findings. J Korean Med Sci 20 (2005) 977-984
10. Nilsson B., Bumming P., Meis-Kindblom J.M., et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era: a population-based study in western Sweden. Cancer 103 (2005) 821-829
11. Tryggvason G., Gislason H.G., Magnusson M.K., et al. Gastrointestinal stromal tumors in Iceland, 1990-2003: the Icelandic GIST study, a population-based incidence and pathologic risk stratification study. Int J Cancer 117 (2005) 289-293
12. Miettinen M., Makhlouf H.R., Sobin L.H., et al. Gastrointestinal stromal tumors (GISTs) of the jejunum and ileum: a clinicopathologic, immunohistochemical and molecular genetic study of 906 cases prior to imatinib with long-term follow-up. Am J Surg Pathol 30 (2006) 477-489
13. Trupiano J.K., Stewart R.E., Misick C., et al. Gastric stromal tumors. A clinicopathologic study of 77 cases with correlation of features with non-aggressive and aggressive behaviors. Am J Surg Pathol 26 (2002) 705-714
14. Wong N.A.C.S., Young R., Malcomson R.D.G., et al. Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology 43 (2003) 118-126
15. Miettinen M., Sobin L.H., and Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic studies of 1765 cases with long-term follow-up. Am J Surg Pathol 29 (2005) 52-68
16. Abraham S.C., Krasinskas A.M., Hofstetter W.L., et al. "Seedling" mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common in the esophagogastric region. Mod Pathol 19 suppl 1 (2006) 100A
17. Appelman H.D., and Helwig E.B. Gastric epithelioid leiomyoma and leiomyosarcoma (leiomyoblastoma). Cancer 38 (1976) 708-728
18. Miettinen M., Kopczynski J., Maklouf H.R., et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas of the duodenum: a clinicopathologic, immunohisto-chemical, and molecular genetic study of 167 cases. Am J Surg Pathol 27 (2003) 625-641
19. Goldblum J.R., and Appelman H.D. Stromal tumors of the duodenum. A histologic and immunohistochemical study of 20 cases. Am J Surg Pathol 19 (1995) 71-80
20. Daum O., Klecka J., Ferda J., et al. Gastrointestinal stromal tumors of the pancreas: case report with documentation of KIT gene mutation. Virchows Arch 446 (2005) 470-472
21. Tworek J.A., Appelman H.D., Singleton T.P., et al. Stromal tumors of the jeujunum and ileum. Mod Pathol 10 (1997) 200-209
22. Min K.-W. Small intestinal stromal tumors with skeinoid fibers. Clinicopathological, immunohistochemical, and ultrastructural investigations. Am J Surg Pathol 16 (1992) 145-155
23. Brainard J.A., and Goldblum J.R. Stromal tumors of the jejunum and ileum: a clinicopathologic study of 39 cases. Am J Surg Pathol 21 (1997) 407-416
24. Yantiss R.K., Rosenberg A.E., Selig M.K., et al. Gastrointestinal stromal tumors: an ultrastructural study. Int J Surg Pathol 10 (2002) 101-113
25. Tworek J., Goldblum J.R., Weiss S.W., et al. Stromal tumors of the abdominal colon. A clinicopathologic study of 20 cases. Am J Surg Pathol 23 (1999) 937-945
26. Miettinen M., Sarlomo-Rikala M., Sobin L.H., et al. Gastrointestinal stromal tumors and leiomyosarcomas in the colon. A clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol 24 (2000) 1339-1352
27. Miettinen M., and Sobin L.H. Gastrointestinal stromal tumors in the appendix. A clinicopathologic and immunohistochemical study of four cases. Am J Surg Pathol 25 (2001) 1433-1437
28. Yap W.M., Tan H.W., Goh S.G.N., et al. Appendiceal gastrointestinal stromal tumor. Letter to the editor. Am J Surg Pathol 29 (2005) 1545-1547
29. Tworek J., Goldblum J.R., Weiss S.W., et al. Stromal tumors of the anorectum. A clinicopathologic study of 22 cases. Am J Surg Pathol 23 (1999) 946-954
30. Miettinen M., Furlong M., Sarlomo-Rikala M., et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus. A clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol 25 (2001) 1121-1133
31. Hassan I., You N., Dozois E.J., et al. Clinical, pathologic, and immunohistochemical characteristics of gastrointestinal stromal tumors of the colon and rectum: implications for surgical management and adjuvant therapies. Dis Col Rectum 49 (2006) 609-615
32. Changchien C.R., Wu M.C., Tasi W.S., et al. Evaluation of prognosis for malignant rectal gastrointestinal stromal tumor by clinical parameters and immunohistochemical staining. Dis Col Rectum 47 (2004) 1922-1929
33. Firoozmand E., Binder S., Thompson A., et al. A gastrointestinal stromal tumor discovered in a resected hemorrhoidal donut after stapled hemorrhoidopexy: report of a case. Am Surg 71 (2005) 155-158
34. Miettinen M., Monihan J.M., Sarlomo-Rikala M., et al. Gastrointestinal stromal tumors/smooth muscle tumors/GISTs in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol 23 (1999) 1109-1118
35. Reith J.D., Goldblum J.R., Lyles R.H., et al. Extragastrointestinal (soft tissue) stromal tumors. An analysis of 48 cases with emphasis on histological predictors of outcome. Mod Pathol 13 (2000) 577-585
36. Yamamoto H., Oda Y., Kawaguchi K., et al. c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue). Am J Surg Pathol 28 (2004) 479-488
37. Agaimy A., and Wunsch P.H. Gastrointestinal stromal tumours: a regular origin in the muscularis propria, but an extremely diverse gross presentation. A rfeview of 200 to critically re-evaluate the concept of so-called extragastrointestinal stromal tumors. Langenbecks Arch Surg (2006) [EPub Jan 2006]
38. Lam M.M., Corless C.L., Goldblum J.R., et al. Extragastrointestinal stromal tumors presenting as vulvovaginal/rectovaginal septal masses: a diagnostic pitfall. Int J Gynecol Pathol 25 (2006) 288-292
39. Lasota J., Carlson J., and Miettinen M. Spindle cell tumor of urinary bladder serosa with phenotypic and genotypic features of gastrointestinal stromal tumor. Arch Pathol Lab Med 124 (2000) 894-897
40. Wingen C.B., Pauwels P.A., Debiec-Rychter M., et al. Uterine gastrointestinal stromal tumor. Gynecol Oncol 97 (2005) 970-972
41. Sakurai S., Hishima T., Takazawa Y., et al. Gastrointestinal stromal tumors and KIT-positive mesenchymal cells in the omentum. Pathol Int 51 (2001) 524-531
42. Ortiz-Hidalgo C., Bojorge B.L., and Albores-Saavedra J. Stromal tumor of the gallbladder with phenotype of interstitial cells of Cajal. A previously unrecognized neoplasm. Am J Surg Pathol 24 (2000) 1420-1423
43. Mendoza-Marin M., Hoang M.P., and Albores-Saavedra J. Malignant stromal tumor of the gallbladder with interstitial cells of Cajal phenotype. Arch Pathol 126 (2002) 481-483
44. Park J.K., Choi S.H., Lee S., et al. Malignant gastrointestinal stromal tumor of the gallbladder. J Korean Med Sci 19 (2004) 763-767
45. Furihata M., Fujimori T., Imura J., et al. Malignant stromal tumor, so called "gastrointestinal stromal tumor", with rhabdomyomatous differentiation occurring in the gallbladder. Pathol Res Pract 201 (2005) 609-613
46. Siddio M.A., East D., Hock Y.L., et al. Gastrointestinal stromal tumor of the pharynx. J Laryngol Otol 118 (2004) 315-316
47. Prakash S., Sarran L., Socci N., et al. Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature. J Pediatr Hematol Oncol 27 (2005) 179-187
48. Miettinen M., Lasota J., and Sobin L.H. Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature. Am J Surg Pathol 29 (2005) 1373-1381
49. Carney J.A. Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney triad): natural history, adrenocortical component, and possible familial occurrence. Mayo Clin Proc 74 (1999) 543-552
50. Takazawa Y., Sakurai S., Sakuma Y., et al. Gastrointestinal stromal tumors of neuro-fibromatosis type I (von Recklinghausen's disease). Am J Surg Pathol 29 (2005) 755-763
51. Andersson J., Sihto H., Meis-Kindblom J.M., et al. NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics. Am J Surg Pathol 29 (2005) 1170-1176
52. Miettinen M., Fetsch J.F., Sobin L.H., et al. Gastrointestinal stromal tumors in patients with neurofibromatosis 1. A clinicopathologic study of 45 patients with long-term follow-up. Am J Surg Pathol 30 (2006) 90-96
53. Kinoshita K., Hirota S., Isozaki K., et al. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients. J Pathol 202 (2004) 80-85
54. Sarlomo-Rikala M., Kovatich A., Barusevicius A., et al. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 11 (1998) 728-734
55. Medeiros F., Corless C.L., Duensing A., et al. KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications. Am J Surg Pathol 28 (2004) 889-894
56. Lasota J., Dansonka-Meiszkowska A., Sobin L.H., et al. A great majority of GISTs with PDGFRA mutations represent gastric tumors with low or no malignant potential. Lab Invest 84 (2004) 874-883
57. Rossi G., Valli R., Bertolini F., et al. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract. Histopathology 46 (2005) 522-531
58. Yi E.S., Strong C.R., Piao Z., et al. Epithelioid gastrointestinal stromal tumor with PDGFRA activating mutation and immunoreactivity. Appl Immunohistochem Mol Morphol 13 (2005) 157-161
59. Duensing A., Joseph N.E., Medeiros F., et al. Protein kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs). Cancer Res 64 (2004) 5127-5131
60. Blay P., Astudillo A., Buesa J.M., et al. Protein kinase C theta is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias. Clin Cancer Res 10 (2004) 4089-4095
61. Motegi A., Sakurai S., Nakayama H., et al. PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors. Pathol Int 55 (2005) 106-112
62. West R.B., Corless C.L., Chen X., et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 165 (2004) 107-113
63. Pauwels P., Debiec-Rychter M., Stul M., et al. Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall. Histopathology 47 (2005) 41-47
64. Torihashi S., Nishi K., Tokutomi Y., et al. Blockade of kit signaling induces transdifferentiation of interstitial cells of Cajal to a smooth muscle phenotype. Gastroenterology 117 (1999) 140-148
65. Sakurai S., Fukasawa T., Chong J.M., et al. Embryonic form of smooth muscle myosin heavy chain (SMEmb/MHC-B) is gastrointestinal stromal tumor and interstitial cell of Cajal. Am J Pathol 154 (1999) 23-28
66. Miettinen M., Sarlomo-Rikala M., Kovatich A.J., et al. Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicaters traits of smooth muscle differentiation. Mod Pathol 12 (1999) 756-762
67. Tsujimura T., Makiishi-Shimobayashi C., Lundkvist J., et al. Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal. Am J Pathol 158 (2001) 817-823
68. Sarlomo-Rikala M., Tjsujimura T., Lendahl U., et al. Patterns of nestin and other intermediate filament expression distinguish between gastrointestinal stromal tumors, leiomyomas and schwannomas. APMIS 110 (2002) 499-507
69. Fletcher C.D., Berman J., Corless C., et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33 (2002) 459-465
70. Gerdes J., Schwab U., Lemke H., et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31 (1983) 13-20
71. Brown D.C., and Gatter K.C. Ki67 protein: the immaculate deception?. Histopathology 40 (2002) 2-11
72. Nakamura N., Yamamoto H., Yao T., et al. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. Hum Pathol 36 (2005) 828-837
73. Carillo R., Candia A., Rodriguez-Peralto J.L., et al. Prognostic significance of DNA ploidy and proliferative index (MIB-1) index in gastrointestinal stromal tumors. Hum Pathol 28 (1997) 160-165
74. Rudolph P., Gloeckner K., Parvaresch R., et al. Immunophenotype, proliferation. DNA ploidy, and biological behavior of gastrointestinal stromal tumors: a multivariate clinicopathologic study 29 (1998) 791-800
75. Emory T.S., Derringer G.A., Sobin L.H., et al. Ki67 (MIB-1) immunohistochemistry as a prognostic factor in gastrointestinal smooth-muscle tumors. J Surg Pathol 2 (1997) 239-242
76. Hall P.A., and McCluggage W.G. Assessing p53 in clinical contexts: unlearned lessons and new perspectives. J Pathol 208 (2006) 1-6
77. Al-Bozom I.A. P53 overexpression in gastrointestinal stromal tumors. Pathol Int 51 (2001) 519-523
78. Feakins R.M. The expression of p53 and bcl-2 in gastrointestinal stromal tumours is associated with anatomic site, and p53 expression is associated with grade and clinical outcome. Histopathology 46 (2005) 270-279
79. Panizo-Santos A., Sola I., Vega F., et al. Predicting metastatic risk of gastrointestinal stromal tumors: role of cell proliferation and cell cycle regulatory proteins. Int J Surg Pathol 8 (2000) 133-144
80. Jianhui C., Yikang J., Yuuin Z., et al. Quantitation of p53 protein expression in gastrointestinal smooth muscle tumors. Chinese Med J 108 (1995) 669-673
81. Lopez-Guerrero J.A., Pellin A., Noguera R., et al. Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumors. Lab Invest 81 (2001) 803-814
82. Schneider-Stock R., Boltze K., Lasota J., et al. High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors. J Clin Oncol 21 (2003) 1688-1697
83. El-Rifai W., Sarlomo-Rikala M., Andersson L.C., et al. DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. Cancer Res 60 (2000) 3899-3903
84. Sabah M., Cummins R., Leader M., et al. Loss of heterozygosity of chromosome 9p and loss of p16 INK4A expression are associated with malignant gastrointestinal stromal tumors. Mod Pathol 17 (2004) 1364-1371
85. Perrone F., Tamborini E., Dagrada G.P., et al. 9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor α gene alterations. Cancer 104 (2005) 159-169
86. Schneider-Stock R., Boltze K., Lasota J., et al. Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study. Clin Cancer Res 11 (2005) 638-645
87. Suster S., Fisher C., and Moran C.A. Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract. Am J Surg Pathol 22 (1998) 863-872
88. Miettinen M., Sarlomo-Rikala M., and Kovatich A. Cell-type- and tumour-type-related patterns of bcl-2 reactivity in mesenchymal cells and soft tissue tumours. Virchows Arch 433 (1998) 255-260
89. Sabah M., Cummins R., Leader M., et al. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors markers with potential prognostic implications. Hum Pathol 37 (2006) 648-655
90. Cunningham R.E., Abbondanzo S.L., Chu W.S., et al. Apoptosis, bcl-2 expression, and p53 expression in gastrointestinal stromal/smooth muscle tumors. Appl Immunohistochem Mol Morphol 9 (2001) 19-23
91. Montgomery E., Abraham S.C., Fisher C., et al. CD44 loss in gastric stromal tumors as a prognostic marker. Am J Surg Pathol 28 (2004) 168-177